Both H19 and TET1, a key regulator of DNA methylation [106,146], were identified to be strong predictive markers for postoperative recurrence of fibroids [143], suggesting that levels of H19 and TET1 could potentially be used as diagnostic/predictive markers [143]. This evidence concerns the gene H19 and leiomyoma.